THB Asset Management’s West Pharmaceutical WST Stock Holding History

THB Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-21,887	Closed	-$1.27M	–	234
2015 Q2	$1.27M	Sell	21,887 -12,179	-36%	-$680K	0.1%	200
2015 Q1	$2.05M	Sell	34,066 -52,920	-61%	-$2.82M	0.14%	194
2014 Q4	$4.63M	Sell	86,986 -830	-0.9%	-$41.5K	0.31%	127
2014 Q3	$3.93M	Buy	87,816 +52,265	+147%	+$2.22M	0.27%	138
2014 Q2	$1.5M	Sell	35,551 -11	-0%	-$471	0.09%	201
2014 Q1	$1.57M	Sell	35,562 -11,694	-25%	-$550K	0.09%	203
2013 Q4	$2.32M	Buy	47,256 +176	+0.4%	+$8.24K	0.13%	193
2013 Q3	$1.94M	Buy	47,080 +4,080	+9%	+$156K	0.12%	204
2013 Q2	$1.51M	Buy	+43,000	New	+$1.42M	0.1%	214

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

THB Asset Management's WST Position: Q3 2015 in Review

THB Asset Management sold out of West Pharmaceutical (WST) in Q3 2015, closing a stake of 21,887 shares — an estimated $1.27M sold.

THB Asset Management first reported a position in WST in Q2 2013 and held it in 9 quarters. The position peaked at $4.63M in Q4 2014. 248 funds tracked by Wall St. Rank hold WST as of Q3 2015.

THB Asset Management reported no remaining West Pharmaceutical position as of Q3 2015 after selling out during the quarter.
THB Asset Management sold 21,887 West Pharmaceutical shares in Q3 2015, an estimated $1.27M.
THB Asset Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 9 quarters.
THB Asset Management's West Pharmaceutical position peaked at $4.63M in Q4 2014.
248 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2015.

Based on THB Asset Management's 13F filing for Q3 2015, filed 16 Oct 2015.